Navigation Links
QBI's PreserveX product passes initial test

Madison, Wis. - Ralph Kauten is taking direct aim at three unfavorable metrics, and one of his newest weapons just passed an early test.

Kauten, CEO of QBI Life Sciences, recently received good news from an initial screening of its PreserveX Polymeric Micelles, a core product. The screening, which employed UGT1A1, an enzyme that metabo......

Full article >>> es that give researchers every reason to believe they may have discovered an effective new drug.

The time consuming and costly nature of drug discovery is one reason that pharmaceutical companies are not working to develop drugs for rare diseases - the cost is higher, and the size of the population that benefits is smaller, making it less likely that "pharma" will recoup its investment.
Full article >>> Kauten said.

Evasive capital?

QBI is a division of Quintessence Biosciences, Inc., which is seeking between $5 million and $10 million in private funding to test its Evade technology in human clinical trials. The technology, developed by UW researchers from a protein that plays a role in digesting food, has been modified to produce a d......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 06/07/06


Related biology technology :

1. cMaster RTplusPCR System for increased sensitivity and product length in RT-PCR
2. Advantages of Roche Applied Science amplification products
3. Find the optimal product for your PCR application
4. Trouble-shooting: No product
5. Find the optimal product for your application
6. Microfluidic analysis of multiplex PCR products for the genotyping of Helicobacter pylori
7. Determination of the Chloramphenicol residues in milk and milk products using LC/MS/MS
8. Using THERMAL DESORPTION GAS CHROMATOGRAPHY for the identification of fragrance and other components in cosmetic products
9. WARF enters licensing agreements for stem cell products
10. Surgical products company wins Governors Business Plan Contest
11. Merge unveils next-generation imaging-informatics product
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/22/2017)... Bahama (PRWEB) , ... March 21, 2017 , ... Okyanos ... educational seminar as part of their live events series, “Stem Cell Therapy: The Next ... cell facility under the 2013 Stem Cell Research and Therapy Act, Okyanos ...
(Date:3/22/2017)... ... March 21, 2017 , ... Benchworks CEO ... Executive Officer Forum on March 23-24 in San Diego. The event is a ... diagnostic industries. , Benchworks Vice President Christian Meyer will also participate in the ...
(Date:3/22/2017)... ... , ... The Conference Forum has announced the launch of the 5th Annual ... 2017, at the Colonnade Hotel in Boston, MA. The CMO Summit is the only ... and support. , “The Chief Medical Officer faces a unique set of challenges at ...
(Date:3/22/2017)... and CARDIFF, UK (PRWEB) , ... March 21, 2017 , ... ... flow and tissue oxygenation, is being explored as a way to track the brain’s ... study on tonic pain activation by cold pressor test ,” published today in the ...
Breaking Biology Technology:
(Date:2/21/2017)... 2017 Der weltweite Biobanking-Sektor wird ... einem Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen ... gilt, um diese Prognose zu realisieren. ... Zu den ... finanziellen Mittel für die Biobank, die Implementierung Zeit sparender ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
(Date:2/9/2017)... , Feb. 9, 2017 The biomass boiler ... of the biomass boiler market globally in terms of ... biomass boilers. The market for biomass boilers has been ... end-user, application, and country/region. The market based on feedstock ... forest residues, biogas & energy crops, urban residues, and ...
Breaking Biology News(10 mins):